Clinical Trial

Buprenorphine for Probationers and Parolees

Study Description

Buprenorphine for Probationers and Parolees: Bridging the Gap Into Treatment

This five-year study will evaluate the effectiveness of the administration of buprenorphine bridge treatment (BBT) to probationers and parolees compared to treatment as usual (TAU), which consists of referral to a community buprenorphine treatment program.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Buprenorphine/Naloxone

Participants will begin buprenorphine pharmacotherapy using the MedicaSafe buprenorphine dispensing device immediately after an on-site intake at a community supervision office and continue such treatment until they are transitioned to community buprenorphine treatment

Treatment as usual

Participants will receive a referral to buprenorphine treatment in the community

Additional Information

Official Study Title

Buprenorphine for Probationers and Parolees: Bridging the Gap Into Treatment

Clinical Trial ID

NCT03616236

ParticipAid ID

en5ZWd